
SGHC Valuation
SGHC Ltd
- Overview
- Forecast
- Valuation
- Earnings
SGHC Relative Valuation
SGHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SGHC is overvalued; if below, it's undervalued.
Historical Valuation
SGHC Ltd (SGHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 18.70 is considered Undervalued compared with the five-year average of 19.99. The fair price of SGHC Ltd (SGHC) is between 10.82 to 18.28 according to relative valuation methord. Compared to the current price of 10.81 USD , SGHC Ltd is Undervalued By 0.11%.
Relative Value
Fair Zone
10.82-18.28
Current Price:10.81
0.11%
Undervalued
18.70
PE
1Y
3Y
5Y
Trailing
Forward
10.48
EV/EBITDA
SGHC Ltd. (SGHC) has a current EV/EBITDA of 10.48. The 5-year average EV/EBITDA is 6.75. The thresholds are as follows: Strongly Undervalued below -1.78, Undervalued between -1.78 and 2.49, Fairly Valued between 11.01 and 2.49, Overvalued between 11.01 and 15.27, and Strongly Overvalued above 15.27. The current Forward EV/EBITDA of 10.48 falls within the Historic Trend Line -Fairly Valued range.
12.60
EV/EBIT
SGHC Ltd. (SGHC) has a current EV/EBIT of 12.60. The 5-year average EV/EBIT is 8.96. The thresholds are as follows: Strongly Undervalued below -3.52, Undervalued between -3.52 and 2.72, Fairly Valued between 15.20 and 2.72, Overvalued between 15.20 and 21.45, and Strongly Overvalued above 21.45. The current Forward EV/EBIT of 12.60 falls within the Historic Trend Line -Fairly Valued range.
2.55
PS
SGHC Ltd. (SGHC) has a current PS of 2.55. The 5-year average PS is 1.16. The thresholds are as follows: Strongly Undervalued below -0.52, Undervalued between -0.52 and 0.32, Fairly Valued between 2.00 and 0.32, Overvalued between 2.00 and 2.84, and Strongly Overvalued above 2.84. The current Forward PS of 2.55 falls within the Overvalued range.
12.03
P/OCF
SGHC Ltd. (SGHC) has a current P/OCF of 12.03. The 5-year average P/OCF is 2.56. The thresholds are as follows: Strongly Undervalued below -6.42, Undervalued between -6.42 and -1.93, Fairly Valued between 7.05 and -1.93, Overvalued between 7.05 and 11.54, and Strongly Overvalued above 11.54. The current Forward P/OCF of 12.03 falls within the Strongly Overvalued range.
15.39
P/FCF
SGHC Ltd. (SGHC) has a current P/FCF of 15.39. The 5-year average P/FCF is 12.63. The thresholds are as follows: Strongly Undervalued below -12.86, Undervalued between -12.86 and -0.11, Fairly Valued between 25.37 and -0.11, Overvalued between 25.37 and 38.11, and Strongly Overvalued above 38.11. The current Forward P/FCF of 15.39 falls within the Historic Trend Line -Fairly Valued range.
SGHC Ltd (SGHC) has a current Price-to-Book (P/B) ratio of 8.38. Compared to its 3-year average P/B ratio of 4.00 , the current P/B ratio is approximately 109.32% higher. Relative to its 5-year average P/B ratio of 5.13, the current P/B ratio is about 63.28% higher. SGHC Ltd (SGHC) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 1.95%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 8.81% , the current FCF yield is about -100.00% lower.
8.38
P/B
Median3y
4.00
Median5y
5.13
0.00
FCF Yield
Median3y
1.95
Median5y
8.81
Competitors Valuation Multiple
The average P/S ratio for SGHC's competitors is 1.56, providing a benchmark for relative valuation. SGHC Ltd Corp (SGHC) exhibits a P/S ratio of 2.55, which is 63.27% above the industry average. Given its robust revenue growth of 25.49%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Performance Decomposition
1Y
3Y
5Y
Market capitalization of SGHC increased by 219.88% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 13.80 to 40.01.
The secondary factor is the Revenue Growth, contributed 25.49%to the performance.
Overall, the performance of SGHC in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch

XENE
Xenon Pharmaceuticals Inc
34.110
USD
+2.03%

WRBY
Warby Parker Inc
23.220
USD
-0.47%

PLMR
Palomar Holdings Inc
121.640
USD
+1.05%

TDC
Teradata Corp
20.160
USD
-1.80%

ACAD
ACADIA Pharmaceuticals Inc
24.820
USD
+0.89%

DEI
Douglas Emmett Inc
14.060
USD
-2.56%

HBI
HanesBrands Inc
4.830
USD
-0.21%

AVA
Avista Corp
37.370
USD
+0.13%

HCC
Warrior Met Coal Inc
60.310
USD
-0.69%

ATKR
Atkore Inc
53.850
USD
-2.07%
FAQ

Is SGHC Ltd (SGHC) currently overvalued or undervalued?
SGHC Ltd (SGHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 18.70 is considered Undervalued compared with the five-year average of 19.99. The fair price of SGHC Ltd (SGHC) is between 10.82 to 18.28 according to relative valuation methord. Compared to the current price of 10.81 USD , SGHC Ltd is Undervalued By 0.11% .

What is SGHC Ltd (SGHC) fair value?

How does SGHC's valuation metrics compare to the industry average?

What is the current P/B ratio for SGHC Ltd (SGHC) as of Aug 11 2025?

What is the current FCF Yield for SGHC Ltd (SGHC) as of Aug 11 2025?

What is the current Forward P/E ratio for SGHC Ltd (SGHC) as of Aug 11 2025?
